Immunoinformatics and vaccine development: an overview AN Oli, WO Obialor, MO Ifeanyichukwu, DC Odimegwu, JN Okoyeh, ... ImmunoTargets and therapy, 13-30, 2020 | 171 | 2020 |
Carbapenem-resistant enterobacteriaceae posing a dilemma in effective healthcare delivery AN Oli, CJ Itumo, PC Okam, IU Ezebialu, KN Okeke, CC Ifezulike, I Ezeobi, ... Antibiotics 8 (4), 156, 2019 | 18 | 2019 |
Biosurfactant production using mutant strains of Pseudomonas aeruginosa and Bacillus subtilis from Agro-industrial Wastes SA Adejumo, AN Oli, EI Okoye, CD Nwakile, CM Ojiako, UM Okezie, ... Advanced Pharmaceutical Bulletin 11 (3), 543, 2021 | 10 | 2021 |
Carbapenem‑resistant enterobacteriaceae posing a dilemma in effective healthcare delivery. Antibiotics Basel. 2019 AN Oli, CJ Itumo, PC Okam, IU Ezebialu, KN Okeke, CC Ifezulike, I Ezeobi, ... | 5 | |
Secondary metabolites of endophytic fungi from Newbouldia laevis and Cassia tora leaves: prospecting for new antimicrobial agents AA Amaechi, AN Oli, UM Okezie, SA Adejumo, CC Abba, IJ Okeke, ... Recent Advances in Anti-Infective Drug Discovery Formerly Recent Patents on …, 2021 | 4 | 2021 |
Classic and Current Opinions in Human Organ and Tissue Transplantation AN Oli, AB Rowaiye, SA Adejumo, FI Anazodo, R Ahmad, S Sinha, ... Cureus 14 (11), 2022 | 1 | 2022 |
Renal architectural changes in Plasmodium berghei inoculated mice MA Omoirri, NU Madubogwu, SE Iloh, SA Adejumo, CM Ojiako GSC Biological and Pharmaceutical Sciences 13 (3), 222-227, 2020 | 1 | 2020 |
Immunomodulatory Benefits of Probiotic Bacteria: A Review of Evidence SA Adejumo, AN Oli, AB Rowaiye, NH Igbokwe, CK Ezejiegu, ZS Yahaya OBM Genetics 7 (4), 1-73, 2023 | | 2023 |